AI Article Synopsis
- The study investigates the effectiveness of different lock solutions (taurolidine and citrate) in preventing infection and malfunction of central venous catheters (CVCs) in hemodialysis patients.
- A total of 1514 patients were analyzed, revealing that taurolidine-based solutions significantly reduced the need for CVC removal due to infection or malfunction compared to citrate-based solutions.
- Although taurolidine showed better results, the study's retrospective nature means its findings should be interpreted carefully, and no definitive conclusions about the superiority of one solution over another can be made.
Article Abstract
Introduction: To prevent infection and thrombosis of central venous catheters (CVCs) in hemodialysis patients, different CVC lock solutions are available. Taurolidine-based solutions and citrate in different concentrations are frequently used, but no definite conclusions with regard to superiority have been drawn.
Methods: In this retrospective, observational, multicenter study, we aimed to assess the risk for removal of CVC due to infection or catheter malfunction in hemodialysis patients with CVC access for different lock solutions: taurolidine, high-concentrated citrate (46.7%) and low-concentrated citrate (4 or 30%). A multivariable Cox-regression model was used to calculate hazard ratio's (HR).
Results: We identified 1514 patients (median age 65 years, 59% male). In 96 (6%) taurolidine-based lock solutions were used. In 1418 (94%) citrate-based lock solutions were used (high-concentrated 73%, low-concentrated 20%). Taurolidine-based lock solutions were associated with a significantly lower hazard for removal of CVC due to infection or malfunction combined (HR 0.34, 95% CI 0.19-0.64), and for removal of CVC due to infection or malfunction separately (HR 0.36, 95% CI 0.15-0.88 and HR0.33, 95% CI 0.14-0.79). High-concentrated citrate lock solutions were not associated with a decreased hazard for our outcomes, compared to low-concentrated citrate lock solutions.
Conclusion: Removal of CVC due to infection or catheter malfunction occurred less often with taurolidine-based lock solutions. We present the largest cohort comparing taurolidine- and citrate-based lock solutions yet. However, due to the retrospective observational nature of this study, conclusions with regard to superiority should be drawn with caution.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8439004 | PMC |
| http://dx.doi.org/10.1186/s12882-021-02519-3 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Comparison of taurolidine with 4% ethylenediaminetetraacetic acid on antimicrobial lock effectiveness: An experimental study.
JPEN J Parenter Enteral Nutr
January 2025
3rd Department of Internal Medicine-Metabolic Care and Gerontology, University Hospital and Medical Faculty in Hradec Kralove, Charles University in Prague, Hradec Kralove, Czech Republic.
Background: Antimicrobial lock therapy is recommended for preventing and treating catheter-related bloodstream infections, but different solutions have uncertain efficacy.
Methods: Two locks, 1.35% taurolidine and 4% ethylenediaminetetraacetic acid (EDTA), were tested on Staphylococcus epidermidis, Staphylococcus aureus, methicillin-resistant S.
In Situ Aqueous Spice Extract-Based Antifungal Lock Strategy for Salvage of Foley's Catheter Biofouled with Biofilm Gel.
Gels
January 2025
Department of Biotechnology, M S Ramaiah Institute of Technology, Bengaluru 560054, Karnataka, India.
forms a gel-like biofilm in the Foley's catheter (FC) causing tenacious biofouling and severe urinary tract infections (UTIs). For the first time, a spice extract-based antifungal lock therapy (ALT) has been developed to inhibit the gel matrix in FC. Aqueous extracts of garlic, clove, and Indian gooseberry were used as ALT lock solutions and tested against biofilm-forming multidrug-resistant clinical isolates of .
View Article and Find Full Text PDFGenome mining and heterologous expression reveal streptacidin, a new lasso peptide from .
Org Biomol Chem
January 2025
State Key Laboratory of Chemical Biology, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai 200032, China.
A lasso peptide biosynthetic gene cluster (BGC) was identified through genome mining in the species CGMCC 4.1857, which was isolated from acidic rhizosphere soil. The BGC was reconstructed in , leading to the heterologous production of a lasso peptide named streptacidin.
View Article and Find Full Text PDFAn Anthracene-Imidazoanthraquinone Conjugate Exhibiting Ratiometric Fluorescence Turn - on Behavior with CN and F Anions.
Chempluschem
January 2025
Department of Chemistry, Institute of Science, Banaras Hindu University, Varanasi, 221005 UP, India.
A new conjugate, 2-(4-(anthracen-9-yl) phenyl)-[1,2-d]imidazole-1H-anthraquninone (AQI) has been designed and synthesized as a molecular probe 4. The photophysical and electrochemical behavior of the probe in the absence and presence of different class of ions were examined in acetonitrile solution. The probe 4 with F and CN anions showed ratiometric fluorescence "turn - On" response due to variation in ICT processes.
View Article and Find Full Text PDFComparison of the use of standard heparin and 0.9% saline as lock solution in hemodialysis catheter: Importance of closure technique.
Int J Artif Organs
January 2025
Konya Şehir Hastanesi, Konya, Turkey.
Background: Bleeding and thrombotic occlusion are complications of Central venous catheters. When selecting a catheter lock solution, factors such as bleeding, thrombotic occlusion, infection, and cost-effectiveness must be considered.
Methods: The study included 35 patients who used heparin as a locking solution and 35 patients who used 0.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!